16 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
6 May 24
Entry into a Material Definitive Agreement
7:31am
that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s
8-K
EX-99.2
3il09jirvbx4k vggscq
14 May 19
Gossamer Bio Announces First Quarter 2019 Financial Results
7:31am
DEF 14A
msm2i9noapdugs
30 Apr 19
Definitive proxy
4:04pm
10-K
2scamdqrqoro wwhl2u
22 Mar 19
Annual report
4:45pm
424B4
h25ke7q1 nzglraa6a5
8 Feb 19
Prospectus supplement with pricing info
4:40pm
S-1/A
i1bay
23 Jan 19
IPO registration (amended)
4:39pm
S-1
t9brw12knz
21 Dec 18
IPO registration
4:39pm
DRS/A
hv38 jb5gb
29 Nov 18
Draft registration statement (amended)
12:00am
DRS
0vnin6liad
11 Oct 18
Draft registration statement
12:00am
- Prev
- 1
- Next